These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 17156405

  • 41. Natural history of metastatic renal cell carcinoma in patients who underwent consultation for allogeneic hematopoietic stem cell transplantation.
    Nakayama K, Tannir NM, Liu P, Wathen JK, Cheng YC, Champlin RE, Ueno NT.
    Biol Blood Marrow Transplant; 2007 Aug; 13(8):975-85. PubMed ID: 17640602
    [Abstract] [Full Text] [Related]

  • 42. [Analyses of the allogeneic stem cell transplantation outcome based on the new risk classification].
    Wake A, Shirakawa K, Kamio M, Yamasaki Y, Sawada H, Izumi Y.
    Rinsho Ketsueki; 2004 Jan; 45(1):48-56. PubMed ID: 14999934
    [Abstract] [Full Text] [Related]

  • 43. Lack of effect of donor-recipient Rh mismatch on outcomes after allogeneic hematopoietic stem cell transplantation.
    Wirk B, Klumpp TR, Ulicny J, Herman JH, Gajewski JL, Martin ME, Emmons RV, Mangan KF.
    Transfusion; 2008 Jan; 48(1):163-8. PubMed ID: 17900280
    [Abstract] [Full Text] [Related]

  • 44. Hyperglycemia during the neutropenic period is associated with a poor outcome in patients undergoing myeloablative allogeneic hematopoietic stem cell transplantation.
    Fuji S, Kim SW, Mori S, Fukuda T, Kamiya S, Yamasaki S, Morita-Hoshi Y, Ohara-Waki F, Honda O, Kuwahara S, Tanosaki R, Heike Y, Tobinai K, Takaue Y.
    Transplantation; 2007 Oct 15; 84(7):814-20. PubMed ID: 17984832
    [Abstract] [Full Text] [Related]

  • 45. High rate of long-term survival for high-risk lymphoma patients treated with hematopoietic stem cell transplantation as consolidation or salvage therapy.
    Espigado I, Ríos E, Marín-Niebla A, Carmona M, Parody R, Pérez-Hurtado JM, Márquez FJ, Urbano-Ispizua A.
    Transplant Proc; 2008 Nov 15; 40(9):3104-5. PubMed ID: 19010208
    [Abstract] [Full Text] [Related]

  • 46. Incidence and outcome of critical illness amongst hospitalised patients with haematological malignancy: a prospective observational study of ward and intensive care unit based care.
    Gordon AC, Oakervee HE, Kaya B, Thomas JM, Barnett MJ, Rohatiner AZ, Lister TA, Cavenagh JD, Hinds CJ.
    Anaesthesia; 2005 Apr 15; 60(4):340-7. PubMed ID: 15766336
    [Abstract] [Full Text] [Related]

  • 47. Fungal infections in recipients of hematopoietic stem cell transplants: results of the SEIFEM B-2004 study--Sorveglianza Epidemiologica Infezioni Fungine Nelle Emopatie Maligne.
    Pagano L, Caira M, Nosari A, Van Lint MT, Candoni A, Offidani M, Aloisi T, Irrera G, Bonini A, Picardi M, Caramatti C, Invernizzi R, Mattei D, Melillo L, de Waure C, Reddiconto G, Fianchi L, Valentini CG, Girmenia C, Leone G, Aversa F.
    Clin Infect Dis; 2007 Nov 01; 45(9):1161-70. PubMed ID: 17918077
    [Abstract] [Full Text] [Related]

  • 48. Survival and predictors of outcome in patients with acute leukemia admitted to the intensive care unit.
    Thakkar SG, Fu AZ, Sweetenham JW, Mciver ZA, Mohan SR, Ramsingh G, Advani AS, Sobecks R, Rybicki L, Kalaycio M, Sekeres MA.
    Cancer; 2008 May 15; 112(10):2233-40. PubMed ID: 18348307
    [Abstract] [Full Text] [Related]

  • 49. The acute physiology and chronic health evaluation III outcome prediction in patients admitted to the intensive care unit after pneumonectomy.
    Keegan MT, Harrison BA, Brown DR, Whalen FX, Cassivi SD, Afessa B.
    J Cardiothorac Vasc Anesth; 2007 Dec 15; 21(6):832-7. PubMed ID: 18068061
    [Abstract] [Full Text] [Related]

  • 50. Critical care of the hematopoietic stem cell transplant recipient.
    Afessa B, Azoulay E.
    Crit Care Clin; 2010 Jan 15; 26(1):133-50. PubMed ID: 19944279
    [Abstract] [Full Text] [Related]

  • 51. Case volume and mortality in haematological patients with acute respiratory failure.
    Lecuyer L, Chevret S, Guidet B, Aegerter P, Martel P, Schlemmer B, Azoulay E.
    Eur Respir J; 2008 Sep 15; 32(3):748-54. PubMed ID: 18448491
    [Abstract] [Full Text] [Related]

  • 52. Outcome of patients with hematological malignancies admitted to the intensive care unit with life-threatening complications.
    Bahammam AS, Basha SJ, Masood MI, Shaik SA.
    Saudi Med J; 2005 Feb 15; 26(2):246-50. PubMed ID: 15770299
    [Abstract] [Full Text] [Related]

  • 53. Long-term follow-up of allogeneic hematopoietic stem cell transplantation for de novo acute myelogenous leukemia with a conditioning regimen of total body irradiation and granulocyte colony-stimulating factor-combined high-dose cytarabine.
    Mori T, Aisa Y, Watanabe R, Yamazaki R, Kato J, Shimizu T, Shigematsu N, Kubo A, Yajima T, Hibi T, Ikeda Y, Okamoto S.
    Biol Blood Marrow Transplant; 2008 Jun 15; 14(6):651-7. PubMed ID: 18489990
    [Abstract] [Full Text] [Related]

  • 54. Nonmyeloablative allogeneic stem cell transplantation in elderly patients with hematological malignancies: results from the GITMO (Gruppo Italiano Trapianto Midollo Osseo) multicenter prospective clinical trial.
    Falda M, Busca A, Baldi I, Mordini N, Bruno B, Allione B, Rambaldi A, Morello E, Narni F, Santarone S, Locatelli F, Bacigalupo A, Gruppo Italiano Trapianto Midollo Osseo (GITMO).
    Am J Hematol; 2007 Oct 15; 82(10):863-6. PubMed ID: 17616972
    [Abstract] [Full Text] [Related]

  • 55. Autoimmune hemolytic anemia following allogeneic hematopoietic stem cell transplantation in adult patients.
    Sanz J, Arriaga F, Montesinos P, Ortí G, Lorenzo I, Cantero S, Puig N, Moscardó F, de la Rubia J, Sanz G, Sanz MA.
    Bone Marrow Transplant; 2007 May 15; 39(9):555-61. PubMed ID: 17351645
    [Abstract] [Full Text] [Related]

  • 56. Transfer of the hematopoietic stem cell transplant patient to the intensive care unit: does it really matter?
    Naeem N, Reed MD, Creger RJ, Youngner SJ, Lazarus HM.
    Bone Marrow Transplant; 2006 Jan 15; 37(2):119-33. PubMed ID: 16273112
    [Abstract] [Full Text] [Related]

  • 57. Hematopoietic stem cell transplantation for hemophagocytic lymphohistiocytosis: a retrospective analysis of data from the Italian Association of Pediatric Hematology Oncology (AIEOP).
    Cesaro S, Locatelli F, Lanino E, Porta F, Di Maio L, Messina C, Prete A, Ripaldi M, Maximova N, Giorgiani G, Rondelli R, Aricò M, Fagioli F.
    Haematologica; 2008 Nov 15; 93(11):1694-701. PubMed ID: 18768529
    [Abstract] [Full Text] [Related]

  • 58. The International Prognostic Index assessed at relapse predicts outcomes of autologous transplantation for diffuse large-cell non-Hodgkin's lymphoma in second complete or partial remission.
    Lerner RE, Thomas W, Defor TE, Weisdorf DJ, Burns LJ.
    Biol Blood Marrow Transplant; 2007 Apr 15; 13(4):486-92. PubMed ID: 17382255
    [Abstract] [Full Text] [Related]

  • 59. Prognostic factors for patients with acute myeloid leukaemia or high-risk myelodysplastic syndromes undergoing myeloablative or non-myeloablative allogeneic blood stem cell transplantation.
    Graef T, Vaupel M, Fenk R, Ruf L, Zohren F, Germing U, Haas R, Kobbe G.
    Hematol Oncol; 2007 Dec 15; 25(4):170-7. PubMed ID: 17579887
    [Abstract] [Full Text] [Related]

  • 60. Allogeneic hematopoietic stem cell transplantation in myelofibrosis: the 20-year experience of the Gruppo Italiano Trapianto di Midollo Osseo (GITMO).
    Patriarca F, Bacigalupo A, Sperotto A, Isola M, Soldano F, Bruno B, van Lint MT, Iori AP, Santarone S, Porretto F, Pioltelli P, Visani G, Iacopino P, Fanin R, Bosi A, GITMO.
    Haematologica; 2008 Oct 15; 93(10):1514-22. PubMed ID: 18728030
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.